| 000 | 01815 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517140758.0 | ||
| 264 | 0 | _c20170510 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-16-2548 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrenberg, Christina D | |
| 245 | 0 | 0 |
_aOCTN1 Is a High-Affinity Carrier of Nucleoside Analogues. _h[electronic resource] |
| 260 |
_bCancer research _c04 2017 |
||
| 300 |
_a2102-2111 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacokinetics |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aCytarabine _xpharmacokinetics |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDipyridamole _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 |
_aOrganic Cation Transport Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSymporters |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aGibson, Alice A | |
| 700 | 1 | _aPounds, Stanley B | |
| 700 | 1 | _aShi, Lei | |
| 700 | 1 | _aRhinehart, Dena P | |
| 700 | 1 | _aLi, Lie | |
| 700 | 1 | _aHu, Shuiying | |
| 700 | 1 | _aDu, Guoqing | |
| 700 | 1 | _aNies, Anne T | |
| 700 | 1 | _aSchwab, Matthias | |
| 700 | 1 | _aPabla, Navjotsingh | |
| 700 | 1 | _aBlum, William | |
| 700 | 1 | _aGruber, Tanja A | |
| 700 | 1 | _aBaker, Sharyn D | |
| 700 | 1 | _aSparreboom, Alex | |
| 773 | 0 |
_tCancer research _gvol. 77 _gno. 8 _gp. 2102-2111 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-16-2548 _zAvailable from publisher's website |
| 999 |
_c26888662 _d26888662 |
||